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DNA damage induces apoptosis and many apoptotic
genes are regulated via alternative splicing (AS), but
little is known about the control mechanisms. Here
we show that ultraviolet irradiation (UV) affects
cotranscriptional AS in a p53-independent way,
through the hyperphosphorylation of RNA poly-
merase II carboxy-terminal domain (CTD) and a
subsequent inhibition of transcriptional elongation,
estimated in vivo and in real time. Phosphomimetic
CTD mutants not only display lower elongation but
also duplicate the UV effect on AS. Consistently, non-
phosphorylatable mutants prevent the UV effect.
Apoptosis promoted by UV in cells lacking p53 is pre-
vented when the change in AS of the apoptotic gene
bcl-x is reverted, confirming the relevance of this
mechanism. Splicing-sensitive microarrays revealed
a significant overlap of the subsets of genes that
have changed AS with UV and those that have
reduced expression, suggesting that transcriptional
coupling to AS is a key feature of the DNA-damage
response.
INTRODUCTION
Alternative pre-mRNA splicing is more a rule than an exception
because it is estimated to affect the expression of nearly 65%
of human genes (Kim et al., 2007). The importance of alternative
splicing (AS) is confirmed by findings that mutations that affect it
are frequent in human hereditary disease (Ca´ceres and Korn-
blihtt, 2002) and because AS factors can be misregulated in
cancer (Karni et al., 2007). It is now well established that splicing
can be cotranscriptional and that AS regulation not only depends
on the interaction of splicing factors, such as serine/arginine-rich
proteins (SR proteins), with their target sequences in the pre-708 Cell 137, 708–720, May 15, 2009 ª2009 Elsevier Inc.mRNA, but is also coupled to RNA polymerase II (Pol II) tran-
scription, similar to what happens with other pre-mRNA pro-
cessing reactions (Bentley, 2005; Kornblihtt et al., 2004; Maniatis
and Reed, 2002). The ways in which transcription regulates AS
involve both the association of splicing factors to the transcribing
polymerase (recruitment coupling) (de la Mata and Kornblihtt,
2006) and modulation of Pol II elongation rates (kinetic coupling)
(de la Mata et al., 2003).
AS seems to play a key role in the responses to DNA damage
as suggested by the large number of apoptotic genes that are
alternatively spliced, with often antagonistic roles of the isoforms
generated. These include genes for several ligands, receptors,
adaptor proteins, and regulators as well as members of the
Bcl-2, caspase, and p53 families (Schwerk and Schulze-Osthoff,
2005). Therefore, it is predicted that splicing factors and compo-
nents of the transcriptionmachinery, including Pol II itself, can be
targets for intracellular cascades that link changes in splicing
patterns to DNA-damage signals. These are particularly impor-
tant for the variety of cellular responses they trigger, aimed at
either repairing the damage or promoting apoptosis to prevent
its expansion. DNA damage can be caused by endogenous
reactive oxygen species and exogenous chemicals like DNA al-
kylating, intercalating, and crosslinking agents, as well as DNA
topoisomerase inhibitors, some of which are widely used in the
chemotherapy of cancer. DNA-damaging radiation includes
X-rays, gamma rays, and ultraviolet irradiation (UV). The molec-
ular responses elicited are complex and vary according to the
nature of the lesion caused by the specific damaging agent
(Skorski, 2002).
A few examples of UV-dependent regulation of AS have been
reported, but the precise underlying mechanism is not known
(Chandler et al., 2006; Katzenberger et al., 2006; Nicholls et al.,
2004). More information is available on the effects of UV treat-
ment on other aspects of mRNA biogenesis and processing.
Inhibition of transcriptional initiation by Pol II was reported to
follow UV treatment (Rockx et al., 2000) and Pol II was demon-
strated to stall at the photolesions themselves (Damsma et al.,
2007). UV inhibits mRNA 30-end formation, via a mechanism
involving the tumor suppressors BRCA-1 and BARD-1. UV-
mediated DNA damage stabilizes BRCA-1/BARD-1 complexes
that sequester the cleavage stimulation factor CstF-50. In
parallel, BRCA-1/BARD-1 complexes display an E3 ubiquitin
ligase activity that specifically ubiquitylates the phosphorylated
form of Pol II (Pol IIO), inducing its degradation by the protea-
some. Because Pol IIO was shown to be necessary for efficient
30-end processing (Hirose and Manley, 1998), these results
were interpreted as an adaptive response in which degradation
of stalled Pol IIO would inhibit the coupled transcription-RNA
processing machinery and facilitate repair (Kleiman and Manley,
2001; Kleiman et al., 2005). Although other interpretations are
possible, these findings highlight the importance of investigating
the transcription/processing coupling as a putative target of
DNA-damage signaling.
In this study we use the AS of the EDI exon (extra domain I,
a.k.a. EDA or EIIIA) of human fibronectin (FN) as a coupling
model. In fact, EDI AS is not only controlled by the SR proteins
SF2/ASF and SRp20 but is also modulated by promoter occupa-
tion (Cramer et al., 1999), transcriptional elongation (de la Mata
et al., 2003; Kadener et al., 2001), and factor recruitment to the
carboxy-terminal domain (CTD) of Pol II (de la Mata and Korn-
blihtt, 2006). We found that low doses of UV upregulate the
inclusion of the EDI exon and the proapoptotic mRNA isoforms
of Bcl-x and caspase 9 (C9). AS is equally affected in transcripts
of DNA templates transfected before or after UV treatment of
cells, which indicates that the effect is not due to the actual
damage of the DNA template in cis. Instead, UV triggers
a systemic mechanism involving the kinetic coupling between
transcription and splicing affecting cotranscriptional AS. Using
fluorescence recovery after photobleaching (FRAP) to measure
Pol II elongation in vivo, we demonstrate that the mechanism
involves inhibition of Pol II elongation through CTD hyperphos-
phorylation. Unlike other cell responses to UV, the effects on
AS are not mediated by the transcription factor p53 and, more-
over, apoptosis promoted by UV in cells lacking this factor is pre-
vented when the change in Bcl-x AS ratio is reverted. Finally,
using a splicing-sensitive human microarray platform, we found
that the subset of genes that change AS with UV is highly
increased among the genes that also downregulate its expres-
sion, suggesting that modulation of AS through its coupling
with transcription is a key feature of the DNA-damage response.
RESULTS AND DISCUSSION
UV Treatment Affects AS
Irradiation of cells in culture with low doses of 254 nm UV (UVC,
10–50 J/m2) caused a 2.5-fold increase in the inclusion levels of
the EDI alternative cassette exon into endogenous FN mRNA
(Figure 1A, lanes 1 and 2). The effect is not restricted to FN
splicing or to cassette exons because UV also affects the
splicing pattern of the bcl-x gene (lanes 3 and 4) by increasing
the relative proportion of the short mRNA isoform resulting
from two competing 50 splice sites. The relative proportion of
the long isoform of C9 mRNA is also increased by UV treatment
(lanes 5 and 6).
Similar effects are observed when cells are treated with
cisplatin (Figure S1 available online), an anticancer drug thatdamages DNA by forming mainly 1,2-d(GpG) intrastrand cross-
links, which differ from the intrastrand cyclobutane pyrimidine
dimers (CPD) and 6-4 photoproducts (6-4PP) provoked by UV.
AS patterns of transfected minigenes are also affected by UV,
and the fold increase observed is comparable with the different
promoters analyzed (Figure 1B). As expected, the magnitude
of changes observedwhen using transfectedminigenes is higher
compared with that of endogenous genes because we are look-
ing at the effects of UV on de novo mRNA synthesis. Changes in
mRNA isoform abundances could be caused by changes in AS
or differential isoform degradation. Figure 1C shows that UV is
acting on AS of the three genes studied here, and not on degra-
dation, because its effect was abolished when transcription was
blocked with actinomycin D before irradiation.
In view of these results, we decided to investigate the mecha-
nism (Figures 2–5), the biological implications (Figure 6), and the
generality (Figure 7) of the UV effect on AS.
DNA Damage In cis Is Not Necessary for the UV Effect
The similar effects of UV and cisplatin indicate that the changes
in AS are triggered by DNA damage. Moreover, lesions in the
DNA template are known to block transcription elongation and
lead to Pol II stalling in cis (Damsma et al., 2007). Because stall-
ing of Pol II can cause changes in AS through kinetic coupling
(Batsche et al., 2006), we decided to investigate whether the
UV effect on AS was caused by lesions on the actual DNA
template in cis. For this, we compared the effects of UV treat-
ment performed either after (AT) or before (BT) transfecting an
EDI reporter minigene, with respect to nonirradiated cells (NI).
Surprisingly, UV caused a similar increase in EDI exon inclusion
(approximately 8-fold) independent of the relative order of trans-
fection and irradiation (Figure 2A). This indicates that damage of
the actual template in cis is not necessary for the observed effect
of UV on AS.
The UV Effect Is Independent of p53
If damage is causative it should be through evoking systemic
responses related to stress signaling that might affect the prop-
erties of nuclear proteins involved in transcription and/or
splicing. Among these, the phosphorylation of the tumor
suppressor p53 is of major importance in the response to geno-
toxic agents (Efeyan and Serrano, 2007). Phosphorylated p53
activates transcription of numerous genes involved in cell cycle
progression and apoptosis. The relevance of p53 is dramatically
illustrated by its need for the most conspicuous effect of UV in
animals: the suntan response. Indeed, mice lacking p53 do not
display hyperpigmentation after UV treatment because tran-
scription of the proopiomelanocortin gene requires p53 (Cui
et al., 2007).
Despite its importance, p53 is not necessary for the UV effect
on AS of FN, Bcl-x, and C9 genes because it takes place in
Hep3B cells that are considered to be p53 null (IARC TP53Muta-
tion Database). To confirm this observation, we used two
isogenic human cell lines (HCT116 p53+/+ and HCT116 p53/),
differing by the knockout of the p53 gene. Indeed, the effects of
UV are still observed in p53/ HCT116 cells for the three genes
analyzed (Figures 2B–2D). Caffeine is a specific inhibitor of ATM
and ATR, the protein kinases that phosphorylate p53 in responseCell 137, 708–720, May 15, 2009 ª2009 Elsevier Inc. 709
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Figure 1. UV Affects AS
(A) UV (UVC, 254 nm) increases the inclusion of the EDI exon into endogenous FN mRNA (lanes 1 and 2) and the relative proportions of the proapoptotic (pro)
isoforms of Bcl-x (lanes 3 and 4) and C9 (lanes 5 and 6) in Hep3B cells. Anti, antiapoptotic.
(B) UVC increases the inclusion of EDI in mRNAs expressed fromminigenes. Hep3B cells were transfected with EDI reporter minigenes with different promoters:
FN, fibronectin; a-gb, alpha globin; Tet-inducible, Tet-off promoter.
(C) In the presence of actinomycin D (added 1 hr before irradiation), there is no change in the proportions of EDI, Bcl-x, and C9 AS isoforms upon UV treatment. In
all experiments, cells were harvested 15 hr after irradiation. AS of FN, Bcl-x, and C9 mRNA isoforms were assessed by radioactive RT-PCR with specific pairs of
primers for the endogenous (FN, Bcl-x, and C9) or minigene-derived (FN) mRNAs, followed by electrophoresis in native polyacrylamide gels as described in
Experimental Procedures. Means and standard deviations (SD) are shown (n = 3).710 Cell 137, 708–720, May 15, 2009 ª2009 Elsevier Inc.
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Figure 2. UV-Induced DNA Damage Affects Cotranscriptional AS through a Systemic and p53-Independent Mechanism
(A) Hep3B cells were transfected with the FN EDI reporter minigene. Cells were either not irradiated (NI, lane 1), irradiated after transfection (AT, lane 2), or
irradiated before transfection (BT, lane 3) with UVC at 40 J/m2, and harvested 15 hr later.
(B–D) The UV effect on AS is observed independent of p53. Wild-type HCT116 (lanes 1 and 2) or p53/ (lanes 3 and 4) cells were irradiated (lanes 2 and 4) o not
irradiated (lanes 1 and 3) with UVC at 40 J/m2. AS was assessed by RT-PCR as in Figure 1 for FN-EDI (B), Bcl-x (C), and C9 (D).
(E) The UV effect is observed when both cotranscriptional and posttranscriptional splicing can occur by transfecting the a-gb-promoter reporter minigene (lanes
1 and 2).
(F) The UV effect is not observed when only posttranscriptional splicing can take place upon direct transfection of an in-vitro-synthesized pre-mRNA. The capped
and polyadenylated pre-mRNAsmade in vitro, corresponding to wt (lanes 1, 2, and 4) minigenes used in (A), were transfected into Hep3B cells with (only lane 4) or
without pretreatment with RNase A. Lane 3 shows transfection with in vitro synthesized, capped, and polyadenylated pre-mRNA from a minigene (DM) that
displays high levels of EDI inclusion due to the optimization of EDI 30 splice site (Fededa et al., 2005). Cells were irradiated (only lane 2) with UVC at 10 J/m2
and harvested 20 hr after irradiation. AS was assessed by radioactive RT-PCR as in Figure 1 with specific primers (see Experimental Procedures). Means
and SD are shown (n = 3).to DNA damage. In agreement with the p53/ cell results,
caffeine does not alter the UV effect on AS (Figure S2A). Similar
results were reported by Chandler et al. (2006) on changes in
MDM2 mRNA isoforms after UV treatment.
The UV Effect Is Not Linked to Defects in 30-End
Processing
A p53-independent pathway triggered by DNA damage that
targets pre-mRNA processing involves the above-mentioned
stabilization of BRCA1/BARD1 complexes induced by DNA
damage, resulting in inhibition of mRNA 30-end formation(Kleiman andManley, 2001). Because splicing and 30-end forma-
tion are coupled (Maniatis and Reed, 2002), we wondered
whether the UV effect on AS was indirectly caused by inhibition
of pre-mRNA cleavage and polyadenylation. Removal of the
poly(A) signal from the template did not abrogate the UV effect
on AS (Figure S2B). Control experiments using oligo-dT affinity
chromatography indicate that deletion of the poly(A) signal
inhibits polyadenylation bymore than 80% (bottom chart). These
experiments, together with evidence that knock down of BRCA1
and BARD1 does not affect the UV effect (Figure S2C), rule out
the polyadenylation pathway.Cell 137, 708–720, May 15, 2009 ª2009 Elsevier Inc. 711
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Figure 3. The UV Effect and CTD Phosphorylation
(A) Western blots for Pol IIO (hyperphosphorylated) and pol(A) (hypophosphorylated) forms from Hep3B cells at different times after UV (20 J/m2) treatment, using
antibodies to total Pol II (N20, Santa Cruz Biotechnology) or specific to CTD phosphorylated at Ser2 (H5, Covance) or Ser5 (H14, Covance). Loading control was
performed with an antibody to Erk2 (Santa Cruz Biotechnology). Quantification of the Pol IIO percent intensities is shown in the plot (right).712 Cell 137, 708–720, May 15, 2009 ª2009 Elsevier Inc.
The UV Effect Is Not Caused by Changes
in SR Protein Localization
UV treatment was previously shown to decrease the nuclear
concentration of splicing factors such as hSlu7 (Shomron
et al., 2005) and hnRNPA1 (van der Houven van Oordt et al.,
2000) by promoting their shuttling to the cytoplasm, which in
turn affected AS. However, the UV doses used in these reports,
ranging from 200 to several thousand J/m2, aremuch higher than
the ones used here (10–50 J/m2). The SR proteins SRp20, SF2/
ASF, and SC35, which regulate EDI exon inclusion, display
different patterns of intranuclear localization. Although SRp20
has a nucleoplasmic homogeneous distribution, SF2/ASF and
SC35 concentrate in ‘‘speckles.’’ At our doses, no changes
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Figure 4. Phosphomimetic CTD Mutants
Duplicate whereas Nonphosphorylatable
CTD Abrogates the UV Effect on AS
(A) Human Pol II mutants carrying in their CTD
repeats glutamic acid residues in replacement of
serines 2 (E2, lanes 2 and 5) or 5 (E5, lanes 3
and 6) duplicate the effects of UV on AS. Hep3B
(lanes 1–3) or HCT116 (lanes 4–6) cells were trans-
fected with a-amanitin-resistant wt (WTres) (lanes 1
and 4) or mutant Pol II large subunits together with
a reporter minigene for EDI AS and treated with
a-manitin as described elsewhere (de la Mata
and Kornblihtt, 2006).
(B) a-Amanitin-resistant polymerases with wt CTD
(lanes 1 and 2) or carrying alanines instead of
serines at positions 2 and 5 (lanes 3 and 4) were
transfected in HCT116 cells and irradiated (lanes
2 and 4) or not irradiated (lanes 1 and 3).
(C) DRB has no effect on basal EDI inclusion in
HCT116 cells but inhibits its stimulation by UV
treatment. RT-PCR (top) and total Pol II western
blot (N20, bottom) of cells transfected with the
Tet-inducible FN minigene, irradiated with UV,
and treated with DRB as indicated. For all
RT-PCRs, means and SD are shown (n = 3).
in the localization of these splicing factors
were observed (Figure S3).
UV Affects Cotranscriptional but
Not Posttranscriptional AS
Splicing can occur both cotranscription-
ally and posttranscriptionally. Whereas
UV stimulation of EDI exon inclusion is
observed in transfections with reporter minigenes (DNA) that
allow for cotranscriptional splicing (Figures 1B, 2A, and 2E),
transfection of in-vitro-transcribed pre-mRNA, a strategy used
before to look at posttranscriptional splicing (Robson-Dixon
and Garcia-Blanco, 2004), allows for AS, but no UV effect is
observed (Figure 2F, lanes 1 and 2). This indicates that the UV
effect on EDI requires cotranscriptional splicing. Different exper-
imental controls support this conclusion. The sequences of the
pre-mRNAs made in vitro or transcribed from the transfected
reporter minigene are identical. The in-vitro-transcribed pre-
mRNA was capped and polyadenylated also in vitro before
transfection, to reduce its degradation and improve its process-
ing once transfected. Using capped and polyadenylated(B) The UV effect is not due to Pol II degradation. Top: Total Pol II western blot (N20) of Hep3B cells at different times after UV treatment (20 J/m2). In lane 4, the
proteasome inhibitor MG132 (2 mM) was added to the cells before irradiation. Bottom: Cells were transfected with a Tet-inducible FNminigene in the presence of
tetracycline. Twelve hours later, MG132 (2 mM)was added (lanes 7 and 8), and 1 hr later the cells were irradiated (lanes 6 and 8) and tetracyclinewaswashed out to
allow transcription for 4 hr. Cells were then harvested, RNA purified, and EDI AS assessed as in Figure 1. Means and SD are shown (n = 3).
(C) Total Pol II western blot (N20) of Hep3B cells, nonirradiated (lanes 1 and 2) or 4 hr after UV treatment (40 J/m2) (lanes 3 and 4). In lanes 2 and 4, the Cdk-9
inhibitor DRB (50 mM) was added to the cells 3 hr before irradiation.
(D) UV treatment promotes CTD phosphorylation at both Ser5 and Ser2 of Pol II engaged in transcription. Top: Diagram of the humanmyc gene. Positions of the
real-time PCR products are indicated relative to myc P2 start site. Bottom: ChIP analysis. ChIP signals for CTD P-Ser5 and P-Ser2, relative to total Pol II, are
shown for nonirradiated (blue) or UV-treated (red) HCT116 cells. Means and SD are shown (n = 4 for the P-Ser5 graph and n = 3 for the P- Ser2 ratio graph).
(E) Time course of the changes in AS for endogenous FN EDI (left), Bcl-x (center), and C9 (right) in Hep3B cells at different times after UV treatment (20 J/m2).
Means and SD are shown (n = 3).Cell 137, 708–720, May 15, 2009 ª2009 Elsevier Inc. 713
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Figure 5. UV Treatment Inhibits Transcriptional Elongation In Vivo
(A) Schematic diagram of the kinetics of mRNA biogenesis in vivo and in real time using FRAP. Micrographs of a nucleus displaying fluorescence intensities at
a single transcription focus before bleaching and during recovery are shown underneath.
(B) ExoLong cells (Boireau et al., 2007) were transfected with vectors expressing MS2-GFP 16 hr before irradiation or not with UVC at 40 J/m2. FRAP was carried
out as described in Experimental Procedures. FRAP curves were obtained by tracking transcription sites in three dimensions for 15 min, with a wide-field micro-
scope. The recovery curve at the bottom corresponds to a control with a slow mutant of human RNA polymerase II as used in Boireau et al. (2007).
(C) Kinetics of mRNA biogenesis in vivo and in real time using FRAP as in (B). ExoShort cells were transfected with vectors expressing MS2-GFP and theWTres or
mutant (E2 or E5) RNA polymerases, and treated with a-amanitin before FRAP.radioactive pre-mRNA, we determined that 66% of the trans-
fected precursor accumulates in the nuclear fraction, showing
a splicing efficiency similar to the one estimated for the splicing
in vitro of precursors with long introns (Lazarev and Manley,
2007). Most importantly, transfection of an in-vitro-synthesized
pre-mRNA with a mutation that optimizes the suboptimal 30
splice site of the EDI exon allows for high EDI inclusion
levels (Figure 2F, lane 3), indicating that the low EDI inclusion
levels observed upon UV treatment (lane 2) are not the result
of an intrinsic impairment of the RNA transfection system.
Treatment of the in vitro synthesized pre-mRNA with RNase
A previous to transfection shows no bona fide mRNA products
in the transfected cells (lane 4), reassuring that the mature
mRNAs can only result from the splicing of the transfected
precursor RNA.714 Cell 137, 708–720, May 15, 2009 ª2009 Elsevier Inc.The UV Effect and Pol II CTD Phosphorylation
The strict need for cotranscriptionality for the UV effect on EDI
splicing drew our attention to the modifications and properties
induced by UV on Pol II. Pol II transcription is inhibited following
DNA damage (Rockx et al., 2000). Two covalent modifications
are associated with this phenomenon. Both UV and cisplatin
induce first the hyperphosphorylation of Pol II’s CTD, followed
by ubiquitylation of the large subunit at non-CTD residues. Ubiq-
uitylation in turn accelerates proteasome-dependent degrada-
tion (Luo et al., 2001; Somesh et al., 2005). Western blots in
Figure 3A using specific antibodies for total Pol II (N20) or Pol II
phosphorylated at Ser2 (H5) or Ser5 (H14) illustrate the time
course of hyperphosphorylation and degradation in our system.
Starting with a 65% of Pol IIO, 3 hr after UV exposure the
maximum phosphorylation level is achieved (95%) and
AD
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Figure 6. The p53-Independent Apoptosis Is Dependent on Bcl-x AS Ratio
(A and B) Hep3B cells were irradiated with different doses of UV and 18 hr later caspase 3 activity (A) or the percentage of annexin-V-positive cells (B) was deter-
mined.
(C) A negative correlation between the Bcl-xL/Bcl-xS ratio and the number of apoptotic cells is observed when Hep3B cells are irradiated with different UV doses
and harvested 18 hr later.
(D) The UV-induced p53-independent apoptosis, measured as caspase 3 activity, is abrogated by Bcl-xL overexpression. As a control for UV-induced caspase 3
activity, HCT116 p53+/+ cells (lanes 1 and 2) were irradiated with 40 J/m2 (lane 2) or not (lane 1). HCT116 p53/ cells (lanes 3 to 6) were irradiated (lanes 4 and 6) or
not (lanes 3 and 5) and transfected with a control plasmid (lanes 3 and 4) or a Bcl-xL expression plasmid (lanes 5 and 6). Caspase 3 activity was determined 18 hr
later. Means and SD are shown (n = 3).degradation becomes evident. This percentage of hyperphos-
phorylation persists for 2 more hours and then decays because
the hyperphosphorylated form IIO is preferentially degraded. At
16 hr degradation is maximal and the percentage of hyperphos-
phorylation falls back to 65%. Both Ser2 and Ser5 are hyper-
phosphorylated with no evident preference. Ubiquitylation is evi-
denced because degradation is prevented by the proteasome
inhibitor MG132 (Figure 4B, top panel). How do these Pol II modi-
fications correlate with the UV effect on AS? Three facts suggest
that the effect on splicing is linked to Pol II hyperphosphorylation
and not to its degradation. First, 3 hr after UV treatment, when
Pol II is hyperphosphorylated but still not significantly degraded,
minigene EDI exon inclusion is stimulated by severalfold
(Figure 3E, left panel, dotted bar). Second, the UV effect is not
affected by the proteasome inhibitor MG132 (Figure 3B, bottom).
Third, Pol II ubiquitylation is performed by the E3 ubiquitin ligase
activity present in the BRCA1/BARD1 complex (Kleiman et al.,
2005; Xia et al., 2003), whose presence we showed to be unnec-
essary for the UV effect (Figure S2C).
CTD hyperphosphorylation caused by DNA damage can be
the consequence of the activation of several kinases, includingCdk-7, Cdk-9, and Abelson tyrosine kinase (Abl). In an attempt
to identify the kinase responsible for the UV effect, we treated
the cells with different drugs. The Abl inhibitor PD166326 does
not interfere with the effect of UV on AS (Figure S4A), in agree-
ment with reports that UV treatment does not activate the Abl
tyrosine kinase (Liu et al., 1996). On the other hand, the DNA-
damaging agent doxorubicin that activates Abl has no effect
on the AS reported here (Figure S4B). However, we found that
the Cdk-9 inhibitor DRB (5,6-dichloro-1-b-D-ribofuranosylbenzi-
midazole) blocks the CTD hyperphosphorylation triggered by UV
(Figure 3C). This not only confirms previous reports that UV acti-
vates Cdk-9 by causing dissociation of the inhibitory small
nuclear RNA 7SK from the P-TEFb complex (Nguyen et al.,
2001) but also suggests that the phosphorylation at Ser5
observed after UV treatment in Figure 3A might be performed
by Cdk-9. Phosphorylation at Ser5 by Cdk-7 is usually associ-
ated with transcription initiation, whereas phosphorylation at
Ser2 by Cdk-9 (a subunit of P-TEFb) is usually associated with
the elongating form of Pol II. However, this might be an oversim-
plification, because it was shown that Ctdk-I, the yeast homolog
to Cdk-9, can phosphorylate in vitro any of the two serinesCell 137, 708–720, May 15, 2009 ª2009 Elsevier Inc. 715
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Figure 7. Splicing-Sensitive Human Microarray Analysis
(A) Distribution of genes that change expression, AS, or both in Hep3B cells, 6 hr after irradiation with 40 J/m2 UV.
(B) Distribution of ASEs that change upon UV treatment corresponding to genes that change or do not change their expression.
(C) Distribution of ASEs that change upon UV treatment in upregulated and downregulated genes.provided that the other one in the same heptad is already phos-
phorylated (Jones et al., 2004).
To determine if the hyperphosphorylation detected by western
blot in the bulk of Pol II was also observed in the Pol II engaged in
transcription, we performed chromatin immunoprecipitation
(ChIP) analysis of a gene (myc) where Pol II distribution has been
characterized in detail in one of our laboratories (Glover-Cutter
et al., 2008). In agreement with the western blot results, UV treat-
ment causes significant hyperphosphorylation of the DNA-asso-
ciated Pol II at both serines along the myc gene between posi-
tions 39 and +4828 (Figure 3D).
Next, we wanted to correlate the time courses of Pol II hyper-
phosphorylation and the AS response. Figure 3E shows that
endogenous AS responses to UV vary with the gene following
a kinetics that, in all three cases, is subsequent to the hyper-
phosphorylation peak. The effect on endogenous FN EDI
splicing, for example, is not seen until 16 hr after irradiation.
However, and as mentioned above, the effect is observed
much earlier with the tetracycline (Tet)-inducible FN minigene
(3 hr, dotted bar), indicating that the 16 hr delay of the endoge-
nous FN gene is probably the time needed to overcome the
steady-state accumulation of the FN mRNA isoforms, whose716 Cell 137, 708–720, May 15, 2009 ª2009 Elsevier Inc.half-lives are approximately 5 or 6 hr regardless of UV treatment
(data not shown).
Different CTD Mutations Duplicate or Abrogate the UV
Effect on AS
We reasoned that if the UV-induced hyperphosphorylation of Pol
II was causing the change in AS, then a similar change should be
seen with a mutant Pol II that mimics the hyperphosphorylated
state, in the absence of UV. For this, we transfected the AS
reporter minigene together with constructs expressing the large
subunit of Pol II bearing either a wild-type (wt) CTD or CTDs
where the serines at positions 2 or 5 were replaced by glutamic
acids that mimic the effects of the phosphorylated serines.
These polymerases carry an additional point mutation that
confers a-amanitin resistance, enabling the inhibition of endog-
enous Pol II without affecting the transfected polymerases (de
la Mata et al., 2003). Figure 4A shows that the replacement of
either Ser2 or Ser5 by Glu (E2 and E5 mutants) stimulates EDI
exon inclusion in two different cell lines, duplicating the effect
of UV on AS. Consistently, when transcription in HCT116 cells
is carried out by a Pol II CTD mutant with all its serines 2 and 5
replaced by alanines (Ala2 and Ala5 double mutant), no effect
of UV onAS is observed (Figure 4B), confirming that theUV effect
is mediated by CTD hyperphosphorylation at serines 2 and 5.
DRB Blocks the UV Effect on AS
The alanine mutant experiment predicts that the inhibition of the
UV-dependent CTD phosphorylation by DRB observed in
Figure 3C should concomitantly abrogate the UV effect on AS.
The difficulty with such an experiment is that DRB per se affects
AS in certain cell lines and genes as it was shown for FN in
Hep3B cells (Nogue´s et al., 2002). Fortunately, in HCT116 cells,
DRB has little effect on basal FN EDI AS (Figure 4C, lanes 1 and
3), which is consistent with the negligible effect of the alanine
mutant on basal EDI ratios (compare lanes 1 and 3 in
Figure 4B). However, DRB clearly blocks the UV effect on AS
(Figure 4C). The western blot at the bottom of Figure 4C certifies
that DRB blocked basal and UV-dependent CTD phosphoryla-
tion in HCT116 cells. The basal AS patterns of Bcl-x and C9
are also affected by the phosphorylation status of the CTD
because they are affected by DRB (Figure S5). These changes
occur in the same direction as those caused by UV. Neverthe-
less, like in the case of EDI, DRB prevents the UV effect on
Bcl-x and C9 AS. Together with the phosphomimetic and non-
phosphorylatable CTDmutations, these experiments strengthen
the causal relationship between CTD hyperphosphorylation and
change in AS.
UV-Triggered DNA Damage Inhibits the Pol II
Elongation Rate In Vivo
Because both Glu for Ser mutants have similar effects on AS,
experiments in Figure 4A do not allow us to define which step
of transcription is involved. To solve this problem, we decided
to analyze the effect of UV on mRNA biogenesis in vivo and in
real time using a MS2-GFP FRAP assay (Boireau et al., 2007;
Darzacq et al., 2007). For this, cells expressing an HIV-1 reporter
taggedwith 24 binding sites for theMS2 phage protein (ExoLong
cells, Boireau et al., 2007) were transfected with a construct ex-
pressing the MS2-GFP fusion protein and irradiated or not irradi-
ated with UV at 40 J/m2. The residency time of nascent mRNAs
at their transcription sites was determined by photobleaching
the MS2-GFP protein bound to RNA (Figure 5A). In untreated
cells, recovery of MS2-GFP occurs in about 6 min. This curve
has been previously interpreted with a two-step model (Boireau
et al., 2007), containing an initial straight line that corresponds to
elongation, followed by an exponential that accounts for 30-end
formation and transcript release (Figure 5B, green curve). One
hour after exposure to UV, a similar curve is obtained, indicating
no major alteration of mRNA biogenesis (red curve). However,
2 hr after UV treatment, recovery of MS2-GFP becomes mark-
edly slower than the one observed in untreated cells (blue curve,
218 s for half-recovery against 123 s in untreated cells). Compar-
ison of the untreated and 2 hr post-UV recovery curves reveals
that their initial straight lines display the same slope up to the first
80 s following bleaching, but that UV-treated cells recovered
more slowly after this time. Because elongation with the Exo-
Long template occurs during the first 148 s (Boireau et al.,
2007), these results indicate that elongation is inhibited by the
UV treatment. The inhibition of elongation is also supported by
the fact that the FRAP behavior upon UV treatment is similar tothe one observed when transcription is carried out by a slow
Pol II mutant (Figure 5B, bottom).
An independent way of assessing the effects of UV on Pol II
elongation is looking at total Pol II distribution along a gene by
ChIP. UV treatment causes an 8-fold decrease in the amounts
of Pol II detected at themyc promoter. However, if we normalize
the +UV and UV ChIP enrichments to 100% at the promoter
region (position +1), the Pol II distribution on the myc gene in
UV-treated cells shows an accumulation toward the promoter-
proximal regions (Figure S6), consistent with an elongation
defect.
In view of results in Figure 4A showing that the E2 and E5 CTD
mutants duplicate the effects of UV on AS, we decided to
investigate the elongation behavior of the E2 and E5 CTD
mutants in vivo, using the MS2-GFP FRAP assay. The mutant
polymerases were transiently transfected into the ExoShort cells
(Boireau et al., 2007), together with MS2-GFP. The endogenous
polymerases were inactivated by a-amanitin, and the remaining
transcription sites were bleached. The recovery time of nascent
RNAs transcribed by the E2 and E5 mutants were considerably
longer than for the wt, a-amanitin-resistant control enzyme
(WTres) (Figure 5C). Indeed, half-recovery occurred in 78 s for
the WTres enzyme, but in 213 s and 270 s for the E2 and E5
mutants, respectively. This longer residency time of the nascent
RNAs is mostly due to an increased time required for their
transcription, rather than an altered 30-end processing of the
transcript. Elongation occurs during the first 60 s in ExoShort
cells. At this time, the E2 and E5 mutants only recovered about
half the signal generated by the wt enzyme (0.43 versus 0.25
and 0.21).
The UV/DRB Apparent Paradox
Interestingly, although UV and DRB have opposite effects on
Pol II phosphorylation, both inhibit Pol II elongation in vivo
(Figure 5 and Darzacq et al., 2007). We speculate that in certain
situations persistent hyperphosphorylation (UV) or hypophos-
phorylation (DRB) might have similar consequences by inter-
fering with the phosphorylation/dephosphorylation cycle needed
for the concerted regulation of transcription initiation, elongation,
termination, and reinitiation. An alternative explanation is that the
CTD has at least two kinds of hyperphosphorylation states, both
of which can be inhibited by DRB. It is conceivable that the CTD
hyperphosphorylation state that inhibits elongation, such as the
one provoked by treatment with UV and mimicked in the E2/E5
mutants, differs from the CTD hyperphosphorylation state of
nonirradiated cells, characteristic of an elongating Pol II. It has
been proposed that during elongation the CTD contains repeats
phosphorylated at both Ser2 and Ser5 residues and that
Ser5 phosphorylation decays, whereas Ser2 phosphorylation
remains, toward the end of the gene. However, the Pol IIO
band observed in western blots, like those in Figures 3A and
3C, does not necessarily contain a homogeneous population
of molecules. The patterns of phosphorylation on individual Pol
II CTDs can vary widely. This variation could be due to differential
phosphorylation of Ser2 versus Ser5 and/or differential phos-
phorylation of the 52 repeats along the length of the CTD. Unfor-
tunately, current methods do not permit an unequivocal assign-
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Greenleaf, 2006). The fact that the E2 and E5 mutations used in
this work are present in all CTD repeats suggests that a homoge-
neous pattern of hyperphosphorylation could be the cause of
lower elongation rates. In any case, results in Figure 5C indicate
that individual replacements of Ser5 or Ser2 by Glu are sufficient
to slow down elongation, which might suggest that an homoge-
neous phosphorylation at any of the two serines regulates elon-
gation. These results reveal a much more complex picture
compared to the acceptedmodel of Ser5-P and Ser-2-P as land-
marks of initiation and elongation, respectively. Inhibition of elon-
gation by either DRB (Nogue´s et al., 2002 and Figure S5) or UV
(Figure 1) affects AS in the same way in Hep3B cells, whereas
in HCT116 cells DRB has little effect per se on EDI inclusion
but clearly abrogates its stimulation by UV (Figure 4C). These
results imply that additional cell-type-specific factors influence
how CTD phosphorylation affects AS.
AS and UV-Induced Apoptosis in the Absence of p53
Because both the short Bcl-x and the long C9 isoform favor
apoptosis, their increase after UV treatment might be physiolog-
ically relevant to prevent the eventual spreading of UV-induced,
unrepaired mutations. Figure S5 indicates that the mechanism
by which UV increases the proapoptotic/antiapoptotic isoform
ratios of Bcl-x and C9 is similar to that of FN EDI and involves
Pol II phosphorylation. A landmark of this effect is that it occurs
in the absence of p53, a factor thought to be almost indispens-
able for the apoptotic response. Nevertheless, apoptosis is stim-
ulated by UV treatment in the p53-null Hep3B cells in a dose-
response manner, as revealed by the use of two different
markers, caspase 3 (Figure 6A) and annexin V (Figure 6B). A
role for Bcl-x in this apoptotic response is suggested by the
negative correlation between the Bcl-xL/Bcl-xS ratio and the
percentage of apoptotic cells upon increasing UV doses
(Figure 6C). To determine if this correlation reflects causality,
we investigated the effects of altering the Bcl-xL/Bcl-xS ratio by
overexpressing the antiapoptotic long isoform (Bcl-xL). For
this, we used p53/HCT116 cells for their high transfection effi-
ciency, needed for this experiment. Figure 6D shows that, like
Hep3B cells, HCT p53/ cells enter apoptosis with UV treat-
ment (lanes 3 and 4), and this response is completely blocked
by Bcl-xL (lanes 5 and 6). This experiment demonstrates that
the change induced by UV on Bcl-x AS is key for the p53-inde-
pendent apoptotic response.
Splicing-Sensitive Microarrays
To assess the generality of the changes in transcription and AS,
Hep3B cells were UV irradiated (or UV treated) with 40 J/m2 UV
and total RNA was isolated 6 hr later, reverse transcribed,
labeled with Cy5 or Cy3 fluorochromes, and hybridized to
a custom splicing-sensitive microarray (MA) as described in
Supplemental Experimental Procedures.
The MA features 1804 AS events (ASEs) in 482 genes (Supple-
mental Spreadsheet 1), with probes covering both constitutive
and alternative exons and exon-exon junctions. The distribution
of the ASE types is illustrated in Figure S7A. Hybridization anal-
ysis revealed that 14.5% (68 genes) of the MA genes change
their mRNA expression level upon UV treatment: among them,718 Cell 137, 708–720, May 15, 2009 ª2009 Elsevier Inc.78% (53 genes) were downregulated and 22% (15 genes) were
upregulated. About 22% (102 genes) showed changes in at least
one ASE with UV (Figure 7A). Most importantly, the proportion of
genes that display AS is substantially higher among the genes
evidencing changes in expression (43/68 genes, 63.2%) than
among the genes that are not affected at the level of expression
(59/401 genes, 14.7%). The genes that display AS changes upon
UV exposure are listed in Table S2. Consistently, more ASEs
change with UV among genes displaying gene expression
changes (108 versus 87) (Figure 7B).
Another MA study (Pan et al., 2004) showed that, like global
transcription profiles, global AS profiles reflect tissue identity.
However, transcription and AS act independently on different
sets of genes to define tissue-specific profiles, which seems
in contrast with the significant fraction of genes showing
changes in both expression and AS in our MAs. This apparent
discrepancy might reflect that changes in gene transcription
that define tissue-specific profiles (perhaps mostly quantitative)
are not relevant for AS, whereas changes in the rate of tran-
scription through the inhibition of elongation appear to be
important for AS, particularly in a stress situation caused by
DNA damage.
Our platform was designed to capture and to define in detail
AS events of genes involved in cancer, cell cycle, cell prolifera-
tion, and cell death, and our results clearly demonstrate that
several AS events of genes belonging to these functional cate-
gories changed upon UV treatment. Furthermore, an ontology
analysis of the genes whose AS was affected by UV showed
an enrichment in molecules involved in cell cycle, regardless of
their transcriptional response (Figure S7B). As far as the ASEs
studied individually in this paper, FN EDI and C9 are present in
the array and changed consistently with UV either in the hybrid-
ization or in the validation.myc is also present and its expression
is downregulated by UV consistently with the 8-fold decrease in
Pol II recruitment to its promoter observed in ChIP.
Taken together, our data indicate that UV does not generally
affect the level of either gene expression or AS, but its effects
are restricted to a subset of responsive genes. However, the
much higher proportion of ASE changes among genes changing
gene expression and the predominance of downregulation
(Figure 7C) are highly consistent with the mechanism described
here.
Concluding Remarks
Inhibition of Pol II elongation has been shown to affect AS of
many genes (de la Mata et al., 2003). In these cases, slowing
down elongation is thought to favor the use of weak or subop-
timal splice sites by increasing a time window opportunity for
their recognition by the splicing machinery before downstream-
stronger sites are synthesized. We show here that UV acts not
only by specifying which genes are turned on and off but also
by affecting transcription elongation and pre-mRNA processing
decisions that in turn influence survival/death cell decisions. Our
results reveal a CTD-dependent elongation response to DNA
damage that slows downPol II elongation, and show how a path-
ological environmental signal affects AS systemically, but not
pleiotropically, through its coupling with transcription.
EXPERIMENTAL PROCEDURES
UV Treatment
UVC was performed using a CL-1000 ultraviolet crosslinker (UVP). Cells were
first washed with phosphate-buffered saline and UV treatment was performed
without cell medium, which was readded immediately after irradiation.
Transfections
Conditions for transfection of human hepatoma Hep3B and HCT116 cells with
AS reporter minigenes driven by constitutive or Tet-inducible promoters were
as described elsewhere (de la Mata et al., 2003).
RNA Preparation and Radioactive RT-PCR Analysis
RNA was purified using TRIzol reagent (Invitrogen). Radioactive reverse-tran-
scriptase polymerase chain reaction (RT-PCR) of endogenous or minigene
transfected EDI analysis were as described by de la Mata et al. (2003). Condi-
tions and primers for Bcl-x and C9 PCR are described in Supplemental
Experimental Procedures.
Pol II Expression Vectors
Conditions for expression of a-amanitin-resistant variants of the largest
subunit of human Pol II (hRpb1) were as described elsewhere (de la Mata
and Kornblihtt, 2006). The expression vectors for Rpb1 with mutant CTDs
are based on pATRpb1 amr.
Pol II ChIP
Pol II ChIP was carried out according to Glover-Cutter et al. (2008), using
specific antibodies to P-Ser5 and P-Ser2 CTD epitopes therein described.
FRAP Analysis
U2OS-clone16 pExo-IRES-TK cells, transfections with vectors expressing
MS2-GFP, and fluorescence analysis of the transcription sites on a wide-field
microscope were as described previously (Boireau et al., 2007). Briefly, we
used a Nikon TE200 equipped for both confocal and wide-field imaging
(1003, NA 1.45). Transcription sites were bleached with the confocal port,
using a circular region of 2.5 micron diameter (bleaching time, 1 s). Images
were recorded with an EM-CCD camera (Cascade 512B, Roper) and
a piezo-motor on the objective, to capture z-stacks every 3 to 12 s. For image
analysis, fluorescence intensities weremeasured in a small parallelepiped (13
1 3 1.5 micron) placed at the most intense area of the transcription site. This
allowed to track transcription sites in three dimensions and to correct for cell
movements. Fluorescence intensities were normalized, and postbleach values
were additionally set to zero.
Apoptosis Determination
Apoptosis was determined by two methods, annexin V or caspase 3 activity.
For annexin V, apoptosis and necrosis secondary to apoptosis were assessed
by annexin V and propidium iodide binding (Annexin-V Apoptosis Detection
Kit, BD Biosciences, San Jose, CA, USA) and flow cytometric analysis
(FACSCalibur, BD Biosciences) with at least 15,000 cells per point. Caspase
3 activity was determined by caspase 3 colorimetric protease assay (Invitro-
gen, catalog number KHZ0022) as described by the manufacturer.
SUPPLEMENTAL DATA
Supplemental Data contain Supplemental Experimental Procedures, seven
figures, two tables, and one spreadsheet and can be found with this article
online at http://www.cell.com/supplemental/S0092-8674(09)00270-0.
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